Assessment of transplant pharmacy services in medical clinics: a national survey

doi:10.5246/jcps.2025.07.050

Journal of Chinese Pharmaceutical Sciences ›› 2025, Vol. 34 ›› Issue (7): 674-681.DOI: 10.5246/jcps.2025.07.050

• Original articles • Previous Articles Next Articles

Assessment of transplant pharmacy services in medical clinics: a national survey

Hui Yang¹^,¹¹^,^#, Xin Yu¹^,¹⁰^,^#, Xiaopeng Hu², Kuifen Ma³^,¹¹, Pan Chen⁴^,¹¹, Xiangduan Liu⁵^,¹¹, Qing Qian⁶^,¹¹, Wenjing Hou⁷^,¹¹, Fang Zeng⁸^,¹¹, Guangzhao Wang⁹^,¹¹, Rongrong Wang³^,¹¹, Zhuoling An¹^,^*()

¹ Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
² Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
³ Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 311500, Zhejiang, China
⁴ Department of Pharmacy, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong, China
⁵ Department of Pharmacy, Fifth Clinical College of Henan University of Traditional Chinese Medicine (Zhengzhou People’s Hospital), Zhengzhou 450000, Henan, China
⁶ Department of Pharmacy, The First People's Hospital of Changzhou, Changzhou 213003, Jiangsu, China
⁷ Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
⁸ Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China
⁹ Department of Pharmacy, The First People’s Hospital of Yulin, Yulin 537000, Guangxi, China
¹⁰ Department of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China
¹¹ National Alliance of Transplant Pharmacists, Hangzhou 311500, Zhejiang, China

Received:2025-02-07 Revised:2025-03-11 Accepted:2025-03-28 Online:2025-07-31 Published:2025-07-31
Contact: Zhuoling An
About author:
^# Hui Yang and Xin Yu contributed equally to this manuscript.

Abstract

Abstract:

Pharmacy clinics, staffed by clinical pharmacists who interact directly with patients, encompass services such as medication reconciliation, education, follow-up visits, and lifestyle guidance. Their primary goal is to enhance patients’ quality of life. Numerous studies, both domestic and international, have highlighted the benefits of pharmacy clinics in optimizing drug therapy quality and reducing treatment costs, particularly for long-term medication management in organ transplant recipients and similar patient groups. Despite these benefits, pharmacy clinics are still in the early stages of development in China. There remains a lack of clarity regarding the specific development and service content of pharmacy clinics tailored for transplant patients. Therefore, this study aimed to assess the current status of pharmacy clinic development for transplant patients in China and provide insights to hospitals for advancing and strengthening transplant pharmacy clinic initiatives.

Key words: Transplant, Pharmacy services, Pharmacist-managed clinics, Survey, China

Supporting:

Hui Yang, Xin Yu, Xiaopeng Hu, Kuifen Ma, Pan Chen, Xiangduan Liu, Qing Qian, Wenjing Hou, Fang Zeng, Guangzhao Wang, Rongrong Wang, Zhuoling An. Assessment of transplant pharmacy services in medical clinics: a national survey[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(7): 674-681.

Figures/Tables 2

References 20

[1]	Dempsey, J.T.; Matta, L.S.; Carter, D.M.; Stevens, C.A.; Stevenson, L.W.; Desai, A.S.; Cheng, J.W. Assessment of drug therapy-related issues in an outpatient heart failure population and the potential impact of pharmacist-driven intervention. J. Pharm. Pract. 2017, 30, 318–323.
[2]	Ma, K.F.; Chen, Y.H.; Jiang, S.P.; Lu, X.Y. The establishment and evaluation of foreign pharmacist-managed clinic. Chin. Pharm. J. 2018, 53, 76–80.
[3]	Taber, D.J.; Spivey, J.R.; Tsurutis, V.M.; Pilch, N.A.; Meadows, H.B.; Fleming, J.N.; McGillicuddy, J.W.; Bratton, C.F.; Treiber, F.A.; Baliga, P.K.; Chavin, K.D. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin. J. Am. Soc. Nephrol. 2014, 9, 960–966.
[4]	Tang, Y.M.; Li, Y.; Song, T.R. Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: a review of immunosuppressant adjustment strategies. Front. Immunol. 2023, 14, 1150341.
[5]	Feng, S.Y.; Chen, P.J.; Wang, N.; Zhao, B.; Lu, Y.Z.; Zhang, Y.H. Exploration of collaborative drug therapy management mode for elderly patients with chronic diseases. J. Chin. Pharm. Sci. 2022, 31, 866–876.
[6]	Cheung, C.Y.; Tang, S.C.W. Personalized immunosuppression after kidney transplantation. Nephrology. (Carlton) 2022, 27, 475–483.
[7]	Zhang, X.Y.; Wan, Q.; Tang, N.J.; Jia, T.; Li, S.C.; Wang, R.L.; Shi, L.W.; Nie, X.Y. A national online survey of pharmacist-managed clinics in tertiary hospitals in China. Chin. J. Pharm. 2021, 56, 849–853.
[8]	Zheng, T.T.; Shao, X.N.; Wu, B.F.; Wang, Z.C.; Zhen, J.C. Investigation and countermeasure research on the current situation of pharmacist-managed clinics in Chinese hospitals. China Hospital. 2020, 24, 5–7.
[9]	Guangdong Pharmaceutical Society. Trial standard of pharmacy clinic. Pharm. Today. 2018, 28, 721–726.
[10]	Zhang, L.; Huang, Y.M.; Huang, X.X.; Liu, K.K.; Yu, Y.Y.; Sun, S.S.; Xiao, J. Ambulatory care pharmacy practice in China: status and future efforts. Int. J. Clin. Pharm. 2020, 42, 321–325.
[11]	Lu, Y.Z. Pharmaceutical practice and value of pharmacists under the new medical reform situation. J. Chin. Pharm. Sci. 2018, 27, 630–636.
[12]	Rodriguez, K.E.; Chelewski, R.J.; Peter, M.E.; Zuckerman, A.D.; Choi, L.; DeClercq, J.; Langone, A. Integrating pharmacists into a kidney transplant clinic: Developing and implementing a collaborative pharmacy practice agreement. J. Am. Pharm. Assoc. 2022, 62, 349–356.
[13]	Schuh, M.J.; Massoglia, G. Pharmacist impact on tacrolimus serum concentrations in liver transplant patients. Consult. Pharm. 2018, 33, 268–272.
[14]	Ma, K.F.; Zhu, S.; Song, W.B.; Lu, X.Y. Establishment and operation effect of pharmacist-managed clinic for transplant recipients. Pharm. Today. 2018, 28, 824–828, 834.
[15]	Yang, X.L.; He, Y.Y.; Yang, R.; Shen, X.Y.; Li, Q.; Bian, Y.; Chen, M.; Yang, Y. Practice of pharmacist-managed clinic and its promoting effect on medical quality in hospitals. Med. Herald. 2023, 42(05), 639–644.
[16]	Zhang, J.P.; Li, C.; Wei, Y.H.; Sun, S.S.; Wu, Z.A. A Brief introduction to the content and model of clinical pharmaceutical servicefor organ transplantation in the United States. China Modern Appl. Pharm. 2021, 38(04), 481–485.
[17]	Yao, Y.; Shi, C.C.; Zhang, J.P.; You, Y.Z.; Ge, W.H. Experience and Insight of Pharmacy Clinics in Hospitals of Leicester University. Pharm. Clin. Res. 2019, 04, 315–317.
[18]	Yang, J.W.; Xu, L.; Xu, Y.; Wen, R.R.; Zhu, W.J. Research and reference of the current qualification examination system for licensed pharmacists (pharmacists) in foreign countries. China Pharmaceutical. Affairs. 2024, 38(04), 476–482.
[19]	Han, R.; Zhao, Z.G. The consensus Chinese pharmacy service standards and charges of experts. Drug Eval. 2016, 13, 8–15, 24.
[20]	Chen, T.T.; Wang, Y.Z.; Tian, D.; Zhang, J.Q.; Xu, Q.; Lv, Q.Z.; Li, X.Y.; Wang, J.N. Follow-up factors contribute to immunosuppressant adherence in kidney transplant recipients. Patient Prefer. Adherence. 2022, 16, 2811–2819.

Assessment of transplant pharmacy services in medical clinics: a national survey

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 20

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zainab A Abbood, Ahmed Hamza AL-Shammari, Eman M. Jasim, Amjad I. Oraibi. Exploring the impact of tacrolimus on kidney transplant recipients: insights into immunological outcomes [J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(8): 737-750.
[2]	Shuilian Qian, Huan Xu, Wenxia Liu, Zhao Yang, Bin Jiang. Current situation of household storage drugs in China: based on a questionnaire survey [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(1): 64-67.
[3]	Jiaqian Chen, Chen Jin, Bolun Xu, Huang Zhan, Rongrong Fu, Fengqin Li, Huilian Huang. Identification of major compounds of total flavonoids from Smilax china and evaluation of anti-inflammatory effect on phenol mucilage-induced pelvic inflammation in rats [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(2): 157-168.
[4]	Yue Zhou, Haishaerjiang Wushouer, Xi Zhang, Jiajia Feng, Likai Lin, Bo Zheng, Xiaodong Guan, Luwen Shi. Antimicrobial stewardship program in China’s tertiary hospitals in 2018: a nationwide cross-sectional online survey [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(12): 994-1007.
[5]	Jie Gu, Yanli Liu, Fengguo Xu, Yongze Zhang, Rong Shao, Tao Lu. Development and challenges of professional Master of pharmacy education in China [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(1): 69-76.
[6]	Zhifeng Nie, Chunxia Man, Xin Yi, Yi Liu, Zhigang Guo, Xiaodong Guan, Luwen Shi. Impact of the zero-markup drug policy on volume of medical service: based on 57 county hospitals of China [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(3): 220-226.
[7]	Xiao Chen, Xiang Gao, Jie Chen, Sheryl L Chow, Moses S.S. Chow. New direction for clinical pharmacy in China: adopting a “form follows function” approach to improve future healthcare outcomes [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 352-360.
[8]	Jing Zhang, Xiaoyu Fan, Hongtao Jin, Xingchao Geng. A general introduction to the development of Good Laboratory Practice in China [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(7): 534-544.
[9]	Journal of Chinese Pharmaceutical Sciences. Journal of Chinese Pharmaceutical Sciences received a number of rewards at the 21st annual meeting of the Society of China University Journals [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(11): 850-850.
[10]	Wenguang Wang. Profs. Pengfei Tu, Xiuwei Yang, and Wanliang Lv from School of Pharmaceutical Sciences, Peking University were elected into the “2015 List of the Highly Cited Scholars in China” [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(3): 228-229.
[11]	Heqing Huang, Jian Han, Jingjing Zhang. The international impact of Chinese academic journals revealed by the "Annual Report for International Citation of Chinese Academic Journals" [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(3): 200-204.
[12]	Journal of Chinese Pharmaceutical Sciences. Journal of Chinese Pharmaceutical Sciences attended the 11th China Science Journal Development Forum [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(10): 699-700.
[13]	Xiaoyuan Zheng, Shixia Zhang, Song Yang, Yanyan Li, Bin Jiang. The impact of drug administration in USA, Europe and Japan on the reform plan in China [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(5): 324-329.
[14]	Fengqin Hou, Yan Wang, Jun Li, Ying Liu, Guiqiang Wang . Management of acute diarrhea in adults in hospitals in Beijing did not adhere well to Manatsathit working party guidelines [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(2): 132-137.
[15]	Journal of Chinese Pharmaceutical Sciences. Journal of Chinese Pharmaceutical Sciences attended the 10th China Science Journal Development Forum [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(11): 809-809.